胸大肌肌皮瓣在面中部组织缺损修复中的临床应用  

Clinical Application of Pectoralis Major Myocutaneous Flap in the Reconstruction of Tissue Defects of Mid-facial

作　　者：吴旭彬[1] 克热木·阿巴斯[1] 阿不都克力木江·买买提[1] 买买提吐逊·吐尔地[1] WU Xubin;Keremu·ABASI;Abudukeimujiang·MAIMAITI;Maimaitituxun·TUERDI

机构地区：[1]新疆医科大学第一附属医院(附属口腔医院)口腔颌面外科,新疆乌鲁木齐830054

出　　处：《中国美容医学》2023年第4期26-29,共4页Chinese Journal of Aesthetic Medicine

基　　金：新疆维吾尔自治区自然科学基金(编号:2021D01C321)。

摘　　要：目的:探讨胸大肌肌皮瓣(Pectoralis major myocutaneous flap,PMMF)修复面中部恶性肿瘤术后软组织缺损的临床效果。方法:选择2018年12月-2021年1月治疗的11例面中部皮肤或累及皮肤的恶性肿瘤患者和1例面中部软硬组织感染缺损患者为研究对象,12例全部利用PMMF进行修复与重建术后面中部软组织缺损,随访观察术后治疗效果。结果:随访6~27个月,平均随访(19.3±6.7)个月,12例患者PMMF全部成活;11例患者受区一期愈合,1例女性患者受区二期愈合(形成面部-鼻腔瘘);8例肿瘤患者经过术后放疗,局部未见明显异常改变;全部患者供区无明显并发症,患者对治疗结果满意。结论:应用PMMF能够满足面中部组织缺损患者的修复需求,是一种有效灵活的修复方式,特别适用于无法开展显微外科的基层单位。Objective To investigate the clinical effect of Pectoralis Major Myocutaneous Flap(PMMF)in repairing soft tissue defects after mid-facial malignant tumor operation.Methods From December 2018 to January 2021,11 cases of middle facial skin or malignant tumors involving skin were treated,and 1 case of middle facial soft and hard tissue defect due to infection.All 12 cases were reconstructed with PMMF.The postoperative treatment effect was followed up.Results All 12 patients were followed up for 6-27 months,with an average follow-up of(19.3±6.7)months.All pectoralis major myocutaneousflaps survived;11 patients healed in stage Ⅰ and 1 female patient healed in stage Ⅱ,a facial-nasal fistula was formed;After postoperative radiotherapy,no obvious abnormal changes were found in 8 tumor patients;All patients had no obvious complications in the donor area,and the patients were satisfied with the treatment results.Conclusion For patients with large area tissue defects in the middle of the face,PMMF can meet the needs of soft tissue defects.It is an ideal repair method,especially in grass-roots units that can not carry out microsurgery.

关 键 词：面中部缺损 重建外科手术 胸大肌 肌皮瓣 整形外科 面部肿瘤 

分 类 号：R622[医药卫生—整形外科]